Klotho Neurosciences Inc. (KLTO)
NASDAQ: KLTO
· Real-Time Price · USD
1.67
0.07 (4.37%)
At close: Jun 16, 2025, 3:59 PM
1.66
-0.30%
After-hours: Jun 16, 2025, 07:59 PM EDT
4.37% (1D)
| Bid | 1.64 |
| Market Cap | 54.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.48M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -7.57 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.66 |
| Volume | 14,145,712 |
| Avg. Volume (20D) | 37,522,317 |
| Open | 1.88 |
| Previous Close | 1.60 |
| Day's Range | 1.57 - 2.00 |
| 52-Week Range | 0.11 - 6.29 |
| Beta | 0.14 |
About KLTO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KLTO
Website n/a
6 days ago
-27.86%
Klotho Neurosciences amends April 2022 Public Warr...
Unlock content with
Pro Subscription
1 week ago
+787.8%
Klotho Neurosciences shares are trading higher after the company announced findings of pre-clinical studies indicating the potential of elevating Klotho gene expression to simultaneously reduce the age-associated degeneration in multiple organs.
